Abstract
Background Throughout the coronavirus disease 2019 (COVID-19) pandemic, there have been a variety of practices for international reporting of COVID-19 data. African countries have used different national reporting systems to publicly share data. Analyzing the content, format, and frequency of these systems could elucidate lessons for future pandemics.
Methods We examined national COVID-19 reporting practices across 54 African countries through 2020. Reporting systems were compared by type of report, frequency, and data content. We also compared reporting of metrics such as a patient demographics and co-morbidities, healthcare capacity, and diagnostic testing. We further evaluated regional and country-specific reporting practices in Cameroon, Egypt, Kenya, Senegal, and South Africa as examples from different sub-regions.
Results National COVID-19 reporting systems were identified in 53/54 (98.1%) countries in 2020. Reporting systems were diverse and could be categorized into social media postings, websites, press releases, situation reports, and online dashboards. Of countries with reporting systems, 36/53 (67.9%) had recurrent situation reports and/or online dashboards which provided the highest quality of data.
Conclusions African countries created diverse reporting systems to share COVID-19 data. Many countries used routinely updated situation reports or online dashboards. However, few countries reported patient demographics, co-morbidities, diagnostic testing practices, and healthcare capacity. Including these metrics as well as improving standardization and accessibility of data reporting systems could augment research and decision-making, as well as increase public awareness and transparency for national governments.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval was not needed for this study
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials. Additional data are available upon request from the corresponding author.
